Reply to Verlingue, Koscielny and Ferté
Eur J Cancer
.
2014 Nov;50(16):2889-91.
doi: 10.1016/j.ejca.2014.08.001.
Epub 2014 Sep 15.
Authors
S Litière
1
,
E G E De Vries
2
,
L Seymour
3
,
D Sargent
4
,
L Shankar
5
,
J Bogaerts
1
;
RECIST committee
Affiliations
1
European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
2
Department of Medical Oncology, University of Groningen, University Medical Center, Groningen, The Netherlands.
3
NCIC Clinical trials group, Queens University, Kingston, Canada.
4
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, United States.
5
NCI Cancer Imaging Program, National Institutes of Health, Bethesda, MA, United States.
PMID:
25219450
DOI:
10.1016/j.ejca.2014.08.001
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms / therapy*
Colorectal Neoplasms / therapy*
Databases, Factual*
Female
Humans
Lung Neoplasms / therapy*
Male
Models, Statistical*
Tumor Burden*